Compare WKSP & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WKSP | BFRI |
|---|---|---|
| Founded | 2003 | 1997 |
| Country | United States | United States |
| Employees | 81 | 94 |
| Industry | Auto Parts:O.E.M. | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.2M | 12.0M |
| IPO Year | N/A | N/A |
| Metric | WKSP | BFRI |
|---|---|---|
| Price | $1.11 | $1.11 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $9.25 | $2.75 |
| AVG Volume (30 Days) | ★ 276.0K | 117.9K |
| Earning Date | 05-14-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $131.96 | $14.36 |
| Revenue Next Year | $24.81 | $16.98 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.83 | $0.54 |
| 52 Week High | $4.90 | $1.18 |
| Indicator | WKSP | BFRI |
|---|---|---|
| Relative Strength Index (RSI) | 48.95 | 61.86 |
| Support Level | $1.00 | $0.79 |
| Resistance Level | $1.44 | $1.08 |
| Average True Range (ATR) | 0.10 | 0.07 |
| MACD | 0.03 | -0.00 |
| Stochastic Oscillator | 71.40 | 57.45 |
Worksport Ltd through its subsidiaries, designs, develops, manufactures, and owns the IP on a variety of tonneau covers, solar integrations, and NP (Non-Parasitic), Hydrogen-based true green energy solutions for the sustainable, clean energy, and automotive industries. The company's product includes soft vinyl tonneau covers and hard aluminum tonneau covers. It operates in two reporting segments for financial reporting purposes: Hard Tonneau Covers and Soft Tonneau Covers. Geographically, the company operates in Canada, United States and Other Countries.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.